海外の治験の状況「1」での検索結果
1245件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Recruiting
- Comparison of NN1250 plus insulin aspart with insulin detemir plus insulin aspart in type 1 diabetes: An extension trial to NN1250-3585
- Type 1 diabetes mellitus
- Brazil, Finland, India, Italy, Japan, United Kingdom
- 2010-10-18
Not recruiting
- Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period
- Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
- Brazil, Russian Federation, Ukraine, United States
- 2011-09-30
Not recruiting
- Glucose Variability in Patients With Type 1 Diabetes With a Sucrose-added Diet
- Type 1 Diabetes Mellitus
- Brazil
- 2016-04-14
Not recruiting
- Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus
- Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus;Type 1 Diabetes Mellitus
- Brazil
- 2006-04-13
Not Recruiting
- "A Phase 3b trial, in type 1 diabetes mellitus, on children who are at least 1 year old to less than 6 years and are given either Lantus (insulin glargine) or Neutral Protamine Hagedorn (NPH) insulin as the medication?.
- Type 1 diabetes mellitus without complications
- Australia, Brazil, Chile, Czech Republic, Germany, Hungary, India, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Turkey, United States of America
- 2010-05-18
Not recruiting
- A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes
- Type 1 Diabetes Mellitus
- Austria, Brazil, China, Czechia, Denmark, France, Germany, Israel, Italy, Japan, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Ukraine, United Kingdom, United States
- 2018-11-12
Recruiting
- A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes
- Type 1 Diabetes Mellitus
- Argentina, China, Mexico
- 2019-05-14
Recruiting
- A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Study To Evaluate The Efficacy And Safety Of Once-Daily Administration Of A Chemokine CCR2/5 Receptor Antagonist (PF-04634817) In Adults With Type 2 Diabetes And Overt Nephropathy
- Diabetic Nephropathy;N08.3 - Glomerular disorders in diabetes mellitus;E11.2 - Non-insulin-dependent diabetes mellitus; With renal complications
- Argentina, Australia, Canada, Germany, Hong Kong, Italy, Korea, Republic of, Malaysia, Peru, Poland, Romania, Spain, United States
- 2015-01-09
- A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-CENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ONCE-DAILY ADMINISTRATION OF A CHEMOKINE CCR2/5 RECEPTOR ANTAGONIST (PF-04634817) IN ADULTS WITH TYPE 2 DIABETES AND OVERT NEPHROPATHY
- -E112 Non-insulin-dependent diabetes mellitus, with renal complications Non-insulin-dependent diabetes mellitus, with renal complications;Non-insulin-dependent diabetes mellitus, with renal complications
- Australia, Brazil, Canada, Germany, India, Italy, Korea South, Poland, Romania, Spain, United States
- 2013-12-27
Not recruiting
- A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen
- HIV Infections;HIV Infections;HIV Infections;HIV Infections
- Argentina, Australia, Chile, China, France, Germany, Hong Kong, India, Ireland, Malaysia, Mexico, New Zealand, Nigeria, Peru, Singapore, South Africa, Taiwan, United Kingdom, Vietnam
- 2009-07-01